KRAS mutation analysis in patients (pts) with locally advanced pancreatic cancer (LAPC) treated with gefitinib and chemoradiation therapy (CT-RT) in a phase I trial.

被引：0
|
作者：
Chen, H.
Raben, D.
Schefter, T.
Kane, M.
McCarter, M.
Olsen, C.
McCoy, K.
Eckhardt, S. G.
Gumerlock, P. H.
机构：
[1] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
[2] Univ Colorado, Boulder, CO 80309 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4106
引用
收藏
页码：204S / 204S
页数：1
相关论文
共 50 条
  • [41] Induction chemotherapy plus gefitinib followed by concurrent chemotherapy/ radiation therapy/gefitinib for patients (pts) with locally advanced squamous carcinoma of the head and neck: A phase I/II trial of the Minnie Pearl Cancer Research Network.
    Doss, H. H.
    Greco, F. A.
    Meluch, A. A.
    Gray, J. R.
    Spigel, D. R.
    Shipley, D. L.
    Barton, J. H.
    Kuzur, M. E.
    Ramsey, S.
    Lunin, S. D.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 290S - 290S
  • [42] Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer
    Magnino, A
    Gatti, M
    Massucco, P
    Sperti, E
    Faggiuolo, R
    Regge, D
    Capussotti, L
    Gabriele, P
    Aglietta, M
    ONCOLOGY, 2005, 68 (4-6) : 493 - 499
  • [43] Impact of radiotherapy (RT) in patients (pts) affected by locally advanced prostate cancer (LAPC) undergoing hormone treatment (HT): Meta-analysis of randomized trials (RCTs).
    Vaccaro, V.
    Bria, E.
    Cuppone, F.
    Milella, M.
    Ruggeri, E.
    Sperduti, I.
    Pinnaro, P.
    Giannarelli, D.
    Cognetti, F.
    Carlini, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] A phase I/II study of induction oxaliplatin, 5FU chemoradiation in patients with locally advanced, unresectable pancreatic cancer
    Leung, R. C.
    Ryan, T.
    Hochster, H.
    Newman, E.
    Chandra, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer (ACC).
    Melichar, B
    Tabernero, J
    Casado, E
    Bridgewater, J
    Hamm, J
    Sklenar, I
    Holland, J
    Cheung, W
    Zaknoen, S
    Johri, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 292S - 292S
  • [46] Second-line therapy with pemetrexed after gemcitabine failure in patients with unresectable locally advanced or metastatic pancreatic cancer:: A multicenter phase II trial.
    Boeck, S.
    Weigang-Koehler, K.
    Fuchs, M.
    Kettner, E.
    Quietzsch, D.
    Trojan, J.
    Stötzer, O.
    Mueller, E.
    Depenbrock, H.
    Heinemann, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 208S - 208S
  • [47] nab-Paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC): Interim efficacy and safety results from the Phase 2 LAPACT Trial
    Philip, P. A.
    Lacy, J.
    Portales, F.
    Sobrero, A.
    Pazo-Cid, R.
    Manzano Mozo, J. L.
    Kim, E. S.
    Dowden, S.
    Zakari, A.
    Borg, C.
    Terrebonne, E.
    Rivera Herrero, F.
    Shiansong Li, J.
    Ong, T. J.
    Nydam, T.
    Hammel, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Phase II LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients with locally advanced pancreatic cancer (LAPC).
    Hammel, Pascal
    Lacy, Jill
    Portales, Fabienne
    Sobrero, Alberto F.
    Cid, Roberto A. Pazo
    Mozo, Jose Luis Manzano
    Mozo, Manzano
    Terrebonne, Eric
    Dowden, Scot D.
    Li, Jack Shiansong
    Ong, Teng Jin
    Nydam, Thom
    Philip, Philip Agop
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [49] A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone
    Kesler, KA
    Helft, PR
    Werner, EA
    Jain, NP
    Brooks, JA
    DeWitt, JM
    Leblanc, JK
    Fineberg, NS
    Einhorn, LH
    Brown, JW
    ANNALS OF THORACIC SURGERY, 2005, 79 (04): : 1116 - 1121
  • [50] HN5: A phase I/II study of erlotinib as adjuvant therapy in patients treated by chemoradiation therapy (CRT) for locally advanced SCCHN
    Soulieres, D.
    Fortin, B.
    Winquist, E.
    Charpentier, D.
    Harnett, E.
    Walsh, W.
    Parulekar, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345